The annual portfolio return for 2024 is around 8%, far below expectations. This is mainly due to significant negative contributions from $PDD(PDD.US) and $Li Auto(LI.US).

Tonight, I will open a new U.S. stock portfolio for 2025, mainly considering the following:

1. Remove Li Auto, continue to hold Pinduoduo and Futu, with a low proportion in Futu, planning to trade when it reaches a new high.

2. The pharmaceutical sector has been bearish for 4 years, remove XBI, focus on holding one quality pharmaceutical stock each from China and the U.S., BeiGene and Regeneron. Currently, they are both at low positions. Their intrinsic value has been increasing, and in the fifth year, the stock price should change, right?

3. The focus in U.S. stocks remains on AI, with slight adjustments. The semiconductor focus is still on TSMC, which is still in a trough. Additionally, shifting towards platforms and applications, optimistic about Claude. Overall, holding Google, Amazon, and Meta. Remove Tesla. New addition is Salesforce, optimistic about AI's early industrialization in the B2B sector.

A total of 10 stocks.